This federal contract award, valued at $5,138.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 60 tablets of 3 mg Risperidone, a generic antipsychotic medication, with a completion date of December 11, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience in supplying essential medical commodities to federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, positions the company as a critical partner in meeting the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/11/25, 10:00 AM